3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Drug-Related Side Effects and Adverse Reactions
3
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematologic Neoplasms
2
Brain Neoplasms
2
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pneumonia
1
Oropharyngeal Neoplasms
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hepatectomy
1
Down Syndrome
1
Cranial Nerve Diseases
1
Interventions
Cyclophosphamide
28
Temozolomide
25
Irinotecan
21
dinutuximab
20
Topotecan
15
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Biopsy
12
naxitamab
11
Granulocyte-Macrophage Colony-Stimulating Factor
11
3-Iodobenzylguanidine
11
Vincristine
10
Etoposide
10
sargramostim
9
Melphalan
9
Isotretinoin
9
fludarabine
8
X-Rays
8
Colony-Stimulating Factors
8
Carboplatin
8
etoposide phosphate
7
Phantoms, Imaging
7
Doxorubicin
7
fludarabine phosphate
6
Stem Cell Transplantation
6
Nuclear Medicine Department, Hospital
6
Eflornithine
6
Thiotepa
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Methylprednisolone
×
1 year
×
Clear all
No trials found.